These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 24276838
1. Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease. Goldman RD, Mounstephen W, Kirby-Allen M, Friedman JN. Pediatrics; 2013 Dec; 132(6):e1634-41. PubMed ID: 24276838 [Abstract] [Full Text] [Related]
4. Magnesium for treating sickle cell disease. Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L. Cochrane Database Syst Rev; 2019 Sep 09; 9(9):CD011358. PubMed ID: 31498421 [Abstract] [Full Text] [Related]
5. The effect of magnesium on length of stay for pediatric sickle cell pain crisis. Brousseau DC, Scott JP, Hillery CA, Panepinto JA. Acad Emerg Med; 2004 Sep 09; 11(9):968-72. PubMed ID: 15347549 [Abstract] [Full Text] [Related]
6. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. Griffin TC, McIntire D, Buchanan GR. N Engl J Med; 1994 Mar 17; 330(11):733-7. PubMed ID: 8107739 [Abstract] [Full Text] [Related]
10. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Buchanan ID, Woodward M, Reed GW. Pediatr Blood Cancer; 2005 Oct 15; 45(5):716-24. PubMed ID: 15926170 [Abstract] [Full Text] [Related]
12. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. Casella JF, Barton BA, Kanter J, Black LV, Majumdar S, Inati A, Wali Y, Drachtman RA, Abboud MR, Kilinc Y, Fuh BR, Al-Khabori MK, Takemoto CM, Salman E, Sarnaik SA, Shah N, Morris CR, Keates-Baleeiro J, Raj A, Alvarez OA, Hsu LL, Thompson AA, Sisler IY, Pace BS, Noronha SA, Lasky JL, de Julian EC, Godder K, Thornburg CD, Kamberos NL, Nuss R, Marsh AM, Owen WC, Schaefer A, Tebbi CK, Chantrain CF, Cohen DE, Karakas Z, Piccone CM, George A, Fixler JM, Singleton TC, Moulton T, Quinn CT, de Castro Lobo CL, Almomen AM, Goyal-Khemka M, Maes P, Emanuele M, Gorney RT, Padgett CS, Parsley E, Kronsberg SS, Kato GJ, Gladwin MT. JAMA; 2021 Apr 20; 325(15):1513-1523. PubMed ID: 33877274 [Abstract] [Full Text] [Related]
14. Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. Badaki-Makun O, Scott JP, Panepinto JA, Casper TC, Hillery CA, Dean JM, Brousseau DC, Pediatric Emergency Care Applied Research Network (PECARN) Magnesium in Sickle Cell Crisis (MAGiC) Study Group. Pediatr Blood Cancer; 2014 Jun 20; 61(6):1049-54. PubMed ID: 24443249 [Abstract] [Full Text] [Related]
18. A randomized controlled trial comparing a fascia iliaca compartment nerve block to a traditional systemic analgesic for femur fractures in a pediatric emergency department. Wathen JE, Gao D, Merritt G, Georgopoulos G, Battan FK. Ann Emerg Med; 2007 Aug 20; 50(2):162-71, 171.e1. PubMed ID: 17210208 [Abstract] [Full Text] [Related]
19. Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation. Robieux IC, Kellner JD, Coppes MJ, Shaw D, Brown E, Good C, O'Brodovich H, Manson D, Olivieri NF, Zipursky A. Pediatr Hematol Oncol; 1992 Aug 20; 9(4):317-26. PubMed ID: 1467165 [Abstract] [Full Text] [Related]